Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus in Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients?
- Status
- COMPLETED
- Phase
- PHASE2
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
- Status
- COMPLETED
- Phase
- N/A
Erlotinib in Higher Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Clofarabine in High Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
- Status
- COMPLETED
- Phase
- PHASE2
A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- N/A
Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients.
- Status
- TERMINATED
- Phase
- PHASE2
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
- Status
- SUSPENDED
- Phase
- PHASE2